Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 26 February 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, on 25 February 2008, in accordance with the Transparency Obligations Directive, a notification of interest in the ordinary share capital of the Company was received from AXA Investment Managers UK Limited on behalf of AXA S.A. and its Group Companies ("AXA"). Details of the notification are as follows: 1. Reason for the notification (please tick the appropriate box or boxes) An acquisition of voting rights X An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its notification obligation: group of companies. 3. Full name of shareholder(s) (if different from 2.): 4. Date of the transaction (and date on which 24 February 2008 the threshold is crossed or reached if different): 5. Date on which issuer notified: 25 February 2008 6. Threshold(s) that is/are crossed or reached: 13% 7. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transaction shares the Triggering transaction if possible using Number of Number of Number of Number of voting rights % of voting rights the ISIN CODE Shares Voting shares Rights Direct Direct Indirect Direct Indirect 0702920 44,103,463 44,103,463 741,666 741,666 43,692,111 0.22% 12.85% B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights instrument Period/ Date that may be acquired if the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 44,433,777 13.07% 8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable : Name of Company/Fund Number of Shares % of issued share capital AXA UK Investment Co ICVC 574,090 0.16887 UK Smaller Companies Fund Indirect Sun Life Pensions Management Ltd 25,000 0.00735 Direct Sun Life Unit Assurance Ltd 53,913 0.01586 FTSE All Share Tracker Life Direct Sun Life Pensions Management 294,874 0.08674 FTSE All Share Tracker Direct AXA Framlington 850,000 0.25003 SEI UK Equity Indirect AXA Framlington 1,851,468 0.54462 St James Place Exempt (Pens) Fund Indirect AXA Framlington 1,909,918 0.56181 St James Place Net (Life) Fund Indirect AXA Framlington 459,865 0.13527 St James Place Offshore Fund Indirect AXA Framlington 639,353 0.18807 Daimler Chrysler Indirect AXA Framlington 3,120,333 0.91787 Throgmorton Trust Indirect AXA Framlington 15,013,453 4.41630 UK Select Ops Indirect AXA Framlington 13,753,131 4.04557 Equity Income Indirect AXA Framlington 2,000,000 0.58831 Managed Balanced Indirect AXA Framlington 1,500,000 0.44123 UK Smaller Companies Indirect AXA Framlington 500,000 0.14708 BAE Systems Pensions Fund CIF Trustees Indirect AXA Framlington 220,000 0.06471 BAE Systems 2000 Pensions Fund Indirect Framlington onshore private clients 975,500 0.28695 Indirect Axa Sun Life With Profits Passive 226,817 0.06672 Direct Axa Sun Life With Profits Passive 141,062 0.04149 Direct AXA Framlington 325,000 0.09560 St James Place Internal Equity & Income UT Indirect Total Direct 741,666 0.21817 Total Indirect 43,692,111 12.85230 TOTAL 44,433,777 13.07047 Proxy Voting: 9. Name of the proxy holder: 10. Number of voting rights proxy holder will cease to hold: 11. Date on which proxy holder will cease to hold voting rights: 12. Additional information: | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK--(Marketwire - February 26, 2008) -